Algo version: 0.98b
Nanjing King-Friend is listed at the SHH Exchange
Nanjing King-Friend [603707.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Nanjing King-Friend stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Nanjing King-Friend pays dividends. Last time was Monday 8th of July 2024 where the investors holding the stock on Monday 8th of July 2024 were paid CNY0.1 per share. Over the last 7 times between 2018 and 2024, Nanjing King-Friend has paid CNY1.17039 with an average of CNY0.17 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Nanjing King-Friend 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY15.52, you would have made a loss of CNY-3.13 per share or -20.17%

Yes, the average daily trading liquidity for Nanjing King-Friend is CNY4.95 million. You should therefore be able to get in and out of your positions relatively fast.

Nanjing King-Friend has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.63, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Nanjing King-Friend to be low [0.45 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.